A novel diagnostic approach using DNA methylation biomarkers from nasal swabs has been developed for nasopharyngeal carcinoma (NPC) detection. Published in BMC Cancer, this noninvasive method automates bilateral nasal sample processing and offers a promising alternative to traditional invasive biopsies. Its epigenetic focus could enable earlier detection of NPC, improving patient outcomes in a cancer type typically diagnosed late due to anatomical inaccessibility.